| |
| |
|
| Insider
Information: |
Patterson Matthew R |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
147,743 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,130,464 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
147,743 |
|
|
| Total
Value |
$1,130,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Acting CEO & President |
2011-04-18 |
106,547 |
|
0 |
Premium* |
|
|
Audentes Therapeutics, Inc. |
BOLD |
Chief Executive Office... |
2020-01-15 |
0 |
2020-01-15 |
0 |
Premium* |
|
|
Vor Biopharma Inc. |
VOR |
Director |
2021-02-04 |
41,196 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VOR |
Vor Biopharma Inc. |
Director |
– • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
41,196 |
|
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
D |
$60.00 |
$10,308,840 |
I/I |
(171,814) |
0 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
D |
$60.00 |
$15,687,480 |
D/D |
(261,458) |
0 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2020-01-08 |
4 |
OE |
$0.78 |
$503,567 |
D/D |
162,538 |
261,458 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
98,920 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-12-05 |
4 |
D |
$59.21 |
$116,881 |
D/D |
(1,974) |
111,420 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-11-08 |
4 |
AS |
$30.00 |
$432,780 |
D/D |
(14,426) |
113,394 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-11-08 |
4 |
OE |
$9.50 |
$137,047 |
D/D |
14,426 |
127,820 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-09-05 |
4 |
D |
$31.02 |
$61,233 |
D/D |
(1,974) |
113,394 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-08-12 |
4 |
AS |
$34.02 |
$680,835 |
D/D |
(20,000) |
115,368 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-08-12 |
4 |
OE |
$9.50 |
$190,000 |
D/D |
20,000 |
135,368 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-06-05 |
4 |
D |
$37.31 |
$124,317 |
D/D |
(3,332) |
115,368 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-25 |
4 |
AS |
$30.00 |
$630,000 |
D/D |
(21,000) |
118,700 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-25 |
4 |
OE |
$0.78 |
$22,020 |
D/D |
21,000 |
122,700 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
63,700 |
118,700 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-12-06 |
4 |
OE |
$0.78 |
$31,200 |
D/D |
40,000 |
55,000 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-01 |
4 |
AS |
$37.70 |
$801,372 |
D/D |
(21,000) |
15,000 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-10-01 |
4 |
OE |
$0.78 |
$16,380 |
D/D |
21,000 |
23,078 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-24 |
4 |
OE |
$0.78 |
$11,700 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-18 |
4 |
AS |
$40.00 |
$518,080 |
D/D |
(12,952) |
0 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-18 |
4 |
OE |
$2.19 |
$28,365 |
D/D |
12,952 |
12,952 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-05 |
4 |
AS |
$40.04 |
$926,852 |
D/D |
(23,147) |
0 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-05 |
4 |
OE |
$0.78 |
$18,055 |
D/D |
23,147 |
23,147 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-03 |
4 |
AS |
$40.05 |
$1,077,460 |
D/D |
(26,901) |
0 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-03 |
4 |
OE |
$0.78 |
$20,983 |
D/D |
26,901 |
26,901 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
